Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. A commentary

Jan Klijn

Research output: Contribution to journalArticleProfessional

Original languageUndefined/Unknown
Pages (from-to)20-21
Number of pages2
JournalActaMed Viewpoint on Oncology
Volume1
Publication statusPublished - 1998

Cite this